Wellington Shields Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
10,659
+1,200
+13% +$65.2K 0.06% 178
2026
Q1
$594K Buy
9,459
+4,200
+80% +$336K 0.09% 140
2025
Q4
$501K Hold
5,259
0.07% 156
2025
Q3
$513K Sell
5,259
-1,500
-22% -$155K 0.08% 151
2025
Q2
$726K Hold
6,759
0.12% 126
2025
Q1
$682K Hold
6,759
0.12% 119
2024
Q4
$604K Hold
6,759
0.11% 133
2024
Q3
$566K Sell
6,759
-75
-1% -$5.91K 0.1% 147
2024
Q2
$526K Sell
6,834
-2,700
-28% -$198K 0.1% 151
2024
Q1
$653K Sell
9,534
-1,266
-12% -$81.4K 0.12% 132
2023
Q4
$624K Hold
10,800
0.08% 132
2023
Q3
$570K Hold
10,800
0.08% 126
2023
Q2
$584K Sell
10,800
-1,800
-14% -$94K 0.07% 134
2023
Q1
$630K Hold
12,600
0.08% 129
2022
Q4
$583K Hold
12,600
0.07% 128
2022
Q3
$488K Hold
12,600
0.12% 138
2022
Q2
$470K Sell
12,600
-36,228
-74% -$1.47M 0.06% 155
2022
Q1
$615K Buy
48,828
+32,728
+203% +$1.42M 0.07% 159
2021
Q4
$684K Buy
+16,100
New +$677K 0.09% 175
2021
Q3
Sell
-17,600
Closed -$753K 266
2021
Q2
$753K Sell
17,600
-170,460
-91% -$7.17M 0.09% 168
2021
Q1
$7.27M Buy
188,060
+164,360
+694% +$6.22M 0.69% 27
2020
Q4
$852K Buy
+23,700
New +$854K 0.11% 139

Other funds holding BSX

Wellington Shields Capital Management's BSX Position: Q2 2026 in Review

Wellington Shields Capital Management increased its Boston Scientific (BSX) stake by 13% in Q2 2026, buying an estimated $65.2K and bringing the position to 10,659 shares worth $455K. The position accounts for 0.06% of the portfolio, ranked #178.

Wellington Shields Capital Management first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.27M in Q1 2021. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wellington Shields Capital Management held 10,659 shares of Boston Scientific worth $455K as of Q2 2026.
  • Wellington Shields Capital Management bought 1,200 Boston Scientific shares in Q2 2026, an estimated $65.2K.
  • Boston Scientific made up 0.06% of Wellington Shields Capital Management's portfolio in Q2 2026, its #178 holding.
  • Wellington Shields Capital Management first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
  • Wellington Shields Capital Management's Boston Scientific position peaked at $7.27M in Q1 2021.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.